These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23849153)

  • 1. Implementing randomized effectiveness trials in large insurance systems.
    Choudhry NK; Shrank WH
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S5-11. PubMed ID: 23849153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.
    Choudhry NK; Brennan T; Toscano M; Spettell C; Glynn RJ; Rubino M; Schneeweiss S; Brookhart AM; Fernandes J; Mathew S; Christiansen B; Antman EM; Avorn J; Shrank WH
    Am Heart J; 2008 Jul; 156(1):31-6. PubMed ID: 18585494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?
    Li G; Sajobi TT; Menon BK; Korngut L; Lowerison M; James M; Wilton SB; Williamson T; Gill S; Drogos LL; Smith EE; Vohra S; Hill MD; Thabane L;
    J Clin Epidemiol; 2016 Dec; 80():16-24. PubMed ID: 27555082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges encountered in the conduct of Optimal Health: A patient-centered comparative effectiveness study of interventions for adults with serious mental illness.
    Kogan JN; Schuster J; Nikolajski C; Schake P; Carney T; Morton SC; Kang C; Reynolds CF
    Clin Trials; 2017 Feb; 14(1):5-16. PubMed ID: 27681658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
    Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
    Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial.
    Kulik A; Desai NR; Shrank WH; Antman EM; Glynn RJ; Levin R; Reisman L; Brennan T; Choudhry NK
    Circulation; 2013 Sep; 128(11 Suppl 1):S219-25. PubMed ID: 24030410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cost-effectiveness of providing full coverage for preventive medications after myocardial infarction.
    Ito K; Avorn J; Shrank WH; Toscano M; Spettel C; Brennan T; Choudhry NK
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):252-9. PubMed ID: 25944633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitis.
    Cross RK; Finkelstein J
    Clin Trials; 2009 Dec; 6(6):649-57. PubMed ID: 19822631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prompted optional randomization trial: a new design for comparative effectiveness research.
    Flory J; Karlawish J
    Am J Public Health; 2012 Dec; 102(12):e8-10. PubMed ID: 23078493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethics of Informed Consent for Pragmatic Trials with New Interventions.
    Kalkman S; Kim SYH; van Thiel GJMW; Grobbee DE; van Delden JJM
    Value Health; 2017; 20(7):902-908. PubMed ID: 28712619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocol.
    Ivers N; Schwalm JD; Witteman HO; Presseau J; Taljaard M; McCready T; Bosiak B; Cunningham J; Smarz S; Desveaux L; Tu JV; Atzema C; Oakes G; Isaranuwatchai W; Grace SL; Bhatia RS; Natarajan M; Grimshaw JM
    Am Heart J; 2017 Aug; 190():64-75. PubMed ID: 28760215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.
    Doll JA; Wang TY; Choudhry NK; Cannon CP; Cohen DJ; Fonarow GC; Henry TD; Bhandary DD; Khan N; Davidson-Ray LD; Anstrom K; Peterson ED
    Am Heart J; 2016 Jul; 177():33-41. PubMed ID: 27297847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polypill strategy to improve adherence: results from the FOCUS project.
    Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Linares JC; García F; D'Aniello F; Arnáiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; Fuster V
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2071-82. PubMed ID: 25193393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans.
    Mazor KM; Sabin JE; Boudreau D; Goodman MJ; Gurwitz JH; Herrinton LJ; Raebel MA; Roblin D; Smith DH; Meterko V; Platt R
    Med Care; 2007 Oct; 45(10 Supl 2):S29-37. PubMed ID: 17909379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.